
Elekta Kaiku is a digital patient monitoring platform that personalizes cancer care through advanced digital support and machine learning. It enables co-creation of therapy-specific modules with life sciences partners to optimize treatment effectiveness and generate robust real-world data for post-marketing commitments. The platform improves patient safety, satisfaction, and treatment coordination while reducing healthcare system burdens. It leverages patient-reported data and machine learning to predict symptom onset and treatment outcomes, supporting personalized cancer care and research.

Elekta Kaiku is a digital patient monitoring platform that personalizes cancer care through advanced digital support and machine learning. It enables co-creation of therapy-specific modules with life sciences partners to optimize treatment effectiveness and generate robust real-world data for post-marketing commitments. The platform improves patient safety, satisfaction, and treatment coordination while reducing healthcare system burdens. It leverages patient-reported data and machine learning to predict symptom onset and treatment outcomes, supporting personalized cancer care and research.
What they do: Digital patient monitoring platform for oncology and other chronic care using patient-reported outcomes and ML
Headquarters: Finland (Helsinki)
Founded: 2012
Employee count: 30
Last known funding: Series A on 2018-04-05
Remote patient monitoring, patient-reported outcomes, oncology support, real-world data collection
2012
Digital health / Healthtech
530000.00 EUR
Seed round reported ~530k (industry database listings)
Series A announced on 2018-04-05
“Debiopharm Innovation Fund; Tesi”